
North America Companion Animal Arthritis Market Size, Share & Industry Trends Analysis Report By Indication (Osteoarthritis and Other Arthritis), By Distribution Channel, By Treatment, By Animal Type, By Country and Growth Forecast, 2022 - 2028
Description
North America Companion Animal Arthritis Market Size, Share & Industry Trends Analysis Report By Indication (Osteoarthritis and Other Arthritis), By Distribution Channel, By Treatment, By Animal Type, By Country and Growth Forecast, 2022 - 2028
The North America Companion Animal Arthritis Market would witness market growth of 5.6% CAGR during the forecast period (2022-2028).
Old age arthritis, often known as osteoarthritis, is a highly prevalent condition that affects both humans and canines. Although other variables including injury, infection, genetic makeup, immunological disease, and cancer can also impact the progression, it is typically caused by continuing wear and tear or instability in the joints. Anywhere in the body, arthritis can impair one or more joints. The hips, knees, shoulders, and elbows are the joints that are most frequently affected in dogs.
In most of these joints, a layer of cartilage serves as a cushion and smooth surface to allow the adjacent bones to move easily over one another. The lubrication that synovial fluid in joints provides facilitates this movement. In cases of arthritis, the cartilage deteriorates as well as the synovial fluid lacks its lubricating characteristics, making it harder for the bones to move smoothly and impairing mobility. Despite the fact that most animals are quite stern and try to conceal signs of pain, there are a number of symptoms that may point to the animal having arthritis.
The region is increasingly focusing on animal health and welfare. Numerous projects and campaigns for animal welfare are underway in this area. For instance, according to the United States Department of Justice Archives, a conference to promote animal welfare was organized by the US Attorneys and Environment and Natural Resources Division. The program's primary goals included promoting animal welfare and combating animal cruelty. These kinds of initiatives would motivate people across the nation to emphasize more on the well-being of pets as well as stray animals.
The US market dominated the North America Companion Animal Arthritis Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $995.9 million by 2028. The Canada market is poised to grow at a CAGR of 8% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 7.1% during (2022 - 2028).
Based on Indication, the market is segmented into Osteoarthritis and Other Arthritis. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, Online Stores and Others. Based on Treatment, the market is segmented into Medication, Supplements and Other Treatment. Based on Animal Type, the market is segmented into Dogs, Cats and Other. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals PLC, Elanco Animal Health, Inc., Zoetis, Inc., Vetoquinol SA, Virbac, Ceva Santé Animale, Eltech K-Laser s.r.l., Norbrook Laboratories Limited, and NexGen Pharmaceuticals, LLC.
Scope of the Study
Market Segments covered in the Report:
By Indication
The North America Companion Animal Arthritis Market would witness market growth of 5.6% CAGR during the forecast period (2022-2028).
Old age arthritis, often known as osteoarthritis, is a highly prevalent condition that affects both humans and canines. Although other variables including injury, infection, genetic makeup, immunological disease, and cancer can also impact the progression, it is typically caused by continuing wear and tear or instability in the joints. Anywhere in the body, arthritis can impair one or more joints. The hips, knees, shoulders, and elbows are the joints that are most frequently affected in dogs.
In most of these joints, a layer of cartilage serves as a cushion and smooth surface to allow the adjacent bones to move easily over one another. The lubrication that synovial fluid in joints provides facilitates this movement. In cases of arthritis, the cartilage deteriorates as well as the synovial fluid lacks its lubricating characteristics, making it harder for the bones to move smoothly and impairing mobility. Despite the fact that most animals are quite stern and try to conceal signs of pain, there are a number of symptoms that may point to the animal having arthritis.
The region is increasingly focusing on animal health and welfare. Numerous projects and campaigns for animal welfare are underway in this area. For instance, according to the United States Department of Justice Archives, a conference to promote animal welfare was organized by the US Attorneys and Environment and Natural Resources Division. The program's primary goals included promoting animal welfare and combating animal cruelty. These kinds of initiatives would motivate people across the nation to emphasize more on the well-being of pets as well as stray animals.
The US market dominated the North America Companion Animal Arthritis Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $995.9 million by 2028. The Canada market is poised to grow at a CAGR of 8% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 7.1% during (2022 - 2028).
Based on Indication, the market is segmented into Osteoarthritis and Other Arthritis. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, Online Stores and Others. Based on Treatment, the market is segmented into Medication, Supplements and Other Treatment. Based on Animal Type, the market is segmented into Dogs, Cats and Other. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals PLC, Elanco Animal Health, Inc., Zoetis, Inc., Vetoquinol SA, Virbac, Ceva Santé Animale, Eltech K-Laser s.r.l., Norbrook Laboratories Limited, and NexGen Pharmaceuticals, LLC.
Scope of the Study
Market Segments covered in the Report:
By Indication
- Osteoarthritis
- Other Arthritis
- Veterinary Hospitals & Clinics
- Retail Pharmacies
- Online Stores
- Others
- Medication
- Supplements
- Other Treatment
- Dogs
- Cats
- Others
- US
- Canada
- Mexico
- Rest of North America
- Boehringer Ingelheim International GmbH
- Dechra Pharmaceuticals PLC
- Elanco Animal Health, Inc.
- Zoetis, Inc.
- Vetoquinol SA
- Virbac
- Ceva Santé Animale
- Eltech K-Laser s.r.l.
- Norbrook Laboratories Limited
- NexGen Pharmaceuticals, LLC
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
77 Pages
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Companion Animal Arthritis Market, by Indication
- 1.4.2 North America Companion Animal Arthritis Market, by Distribution Channel
- 1.4.3 North America Companion Animal Arthritis Market, by Treatment
- 1.4.4 North America Companion Animal Arthritis Market, by Animal Type
- 1.4.5 North America Companion Animal Arthritis Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market composition and scenario
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. North America Companion Animal Arthritis Market by Indication
- 3.1 North America Osteoarthritis Market by Country
- 3.2 North America Other Arthritis Market by Country
- Chapter 4. North America Companion Animal Arthritis Market by Distribution Channel
- 4.1 North America Veterinary Hospitals & Clinics Market by Country
- 4.2 North America Retail Pharmacies Market by Country
- 4.3 North America Online Stores Market by Country
- 4.4 North America Others Market by Country
- Chapter 5. North America Companion Animal Arthritis Market by Treatment
- 5.1 North America Medication Market by Country
- 5.2 North America Supplements Market by Country
- 5.3 North America Other Treatment Market by Country
- Chapter 6. North America Companion Animal Arthritis Market by Animal Type
- 6.1 North America Dogs Market by Country
- 6.2 North America Cats Market by Country
- 6.3 North America Others Market by Country
- Chapter 7. North America Companion Animal Arthritis Market by Country
- 7.1 US Companion Animal Arthritis Market
- 7.1.1 US Companion Animal Arthritis Market by Indication
- 7.1.2 US Companion Animal Arthritis Market by Distribution Channel
- 7.1.3 US Companion Animal Arthritis Market by Treatment
- 7.1.4 US Companion Animal Arthritis Market by Animal Type
- 7.2 Canada Companion Animal Arthritis Market
- 7.2.1 Canada Companion Animal Arthritis Market by Indication
- 7.2.2 Canada Companion Animal Arthritis Market by Distribution Channel
- 7.2.3 Canada Companion Animal Arthritis Market by Treatment
- 7.2.4 Canada Companion Animal Arthritis Market by Animal Type
- 7.3 Mexico Companion Animal Arthritis Market
- 7.3.1 Mexico Companion Animal Arthritis Market by Indication
- 7.3.2 Mexico Companion Animal Arthritis Market by Distribution Channel
- 7.3.3 Mexico Companion Animal Arthritis Market by Treatment
- 7.3.4 Mexico Companion Animal Arthritis Market by Animal Type
- 7.4 Rest of North America Companion Animal Arthritis Market
- 7.4.1 Rest of North America Companion Animal Arthritis Market by Indication
- 7.4.2 Rest of North America Companion Animal Arthritis Market by Distribution Channel
- 7.4.3 Rest of North America Companion Animal Arthritis Market by Treatment
- 7.4.4 Rest of North America Companion Animal Arthritis Market by Animal Type
- Chapter 8. Company Profiles
- 8.1 Boehringer Ingelheim International Gmbh
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Regional & Segmental Analysis
- 8.1.4 Research & Development Expenses
- 8.2 Dechra Pharmaceuticals PLC
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental & Regional Analysis
- 8.2.4 Research & Development Expenses
- 8.3 Elanco Animal Health, Inc.
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Regional Analysis
- 8.3.4 Research & Development Expense
- 8.3.5 Recent strategies and developments:
- 8.3.5.1 Acquisition and Mergers:
- 8.4 Zoetis, Inc.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional Analysis
- 8.4.4 Research & Development Expense
- 8.4.5 Recent strategies and developments:
- 8.4.5.1 Product Launches and Product Expansions:
- 8.4.5.2 Acquisition and Mergers:
- 8.4.5.3 Geographical Expansions:
- 8.5 Vetoquinol SA (Soparfin SCA)
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.6 Virbac
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Regional Analysis
- 8.6.4 Research & Development Expenses
- 8.7 Ceva Santé Animale
- 8.7.1 Company Overview
- 8.8 Eltech K-Laser s.r.l.
- 8.8.1 Company Overview
- 8.9 Norbrook Laboratories Limited
- 8.9.1 Company Overview
- 8.10. NexGen Pharmaceuticals, LLC
- 8.10.1 Company Overview
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.